833 Blockade of human LILRB4/ILT3 inhibits the formation of lung metastasis in melanoma model

Darya Khantakova; Martina Molgora; Julie Roda; Geoffrey Stone; Susan Gilfillan; Tihana Trsan; Marina Cella; Alan Kutach; Daniel Kaplan; Jer-Yuan Hsu; Marco Colonna

doi:10.1136/jitc-2022-SITC2022.0833

Article info

PDF

Regular and Young Investigator Award Abstracts

Combination Immunotherapies

833 Blockade of human LILRB4/ILT3 inhibits the formation of lung metastasis in melanoma model

Free

Authors

Darya Khantakova Washington University School of Medicine, St. Louis, MO, United States PubMed articles Google scholar articles
Martina Molgora Washington University School of Medicine, St. Louis, MO, United States PubMed articles Google scholar articles
Julie Roda NGM Biopharmaceuticals, South San Francisco, CA, United States PubMed articles Google scholar articles
Geoffrey Stone NGM Biopharmaceuticals, South San Francisco, CA, United States PubMed articles Google scholar articles
Susan Gilfillan Washington University School of Medicine, St. Louis, MO, United States PubMed articles Google scholar articles
Tihana Trsan Washington University School of Medicine, St. Louis, MO, United States PubMed articles Google scholar articles
Marina Cella Washington University School of Medicine, St. Louis, MO, United States PubMed articles Google scholar articles
Alan Kutach NGM Biopharmaceuticals, South San Francisco, CA, United States PubMed articles Google scholar articles
Daniel Kaplan NGM Biopharmaceuticals, South San Francisco, CA, United States PubMed articles Google scholar articles
Jer-Yuan Hsu NGM Biopharmaceuticals, South San Francisco, CA, United States PubMed articles Google scholar articles
Marco Colonna Washington University School of Medicine, St. Louis, MO, United States PubMed articles Google scholar articles

Citation

Khantakova D, Molgora M, Roda J, et al

833 Blockade of human LILRB4/ILT3 inhibits the formation of lung metastasis in melanoma model

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0833

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password